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Effects of obesity on mortality in
patients with unstable angina
or non-ST-elevation myocardial
infarction
In a recent article, Buettner et al.1 proposed
that obesity is associated with improved
outcome in coronary artery disease patients
after early revascularization because of
UA/NSTEMI over a mean follow-up time of
17 months. The data presented in the ﬁrst
ﬁgure suggest that severity of obesity is
inversely related to cumulative 3-year cardi-
ovascular mortality. Although one would
wish that—in addition to its known deleter-
ious metabolic effects and the accelerated
development of atherosclerosis2,3—obesity
may have cardiovascular beneﬁts, the data
and conclusions presented by Buettner
et al. should be interpreted with great
caution. Comparing the baseline data of
normal weight patients (n ¼ 551) with
those of severely obese patients (n ¼ 48)
presented by Buettner et al.,1 in the
former group, there were three times as
many patients with prior myocardial infarc-
tion (37 vs. 13%), three times as many who
had undergone coronary artery bypass
surgery (12 vs. 4%), and almost ﬁve times
as many with a systolic left ventricular ejec-
tion fraction of less than 40% (19 vs. 4%).
With regard to medical therapy, obese
patients more often received renin–angio-
tensin system inhibitor (64 vs. 51%) or
statin therapy (70 vs. 57%). It should also
be noted that although there were twice as
many diabetics among the severely obese
patients (31 vs. 17%), only 6% of these
patients received oral anti-diabetic therapy
and none of them was treated with insulin.
Finally, data on weight development and
physical activity during follow-up are not
available.
We ﬁnd it difﬁcult to follow the conclusion
put forward by the authors. It is highly likely
that the reported improvement in outcome
is due to the better overall cardiovascular
status, treatment, or changes in lifestyle of
obese patients. Indeed, previous myocardial
infarction, poor systolic left ventricular
function, and extensive atherosclerotic cor-
onary artery disease are associated with
poor outcome,4 whereas the renin–angioten-
sin system inhibitor or statin therapy
improves survival in patients with coronary
artery disease.4 Similarly, weight loss and/
or exercise are known to improve
cardiovascular function and mortality.5 In
view of the known deleterious effects of
obesity and its associated conditions hyper-
tension, insulin resistance, diabetes, and
dyslipidaemia3 and given that its prevalence
goes much under-diagnosed in European
countries,6 it appears daring to propose a
beneﬁcial effect of obesity according to
the conclusions of Buettner et al. We also
believe that early recognition and preven-
tion of obesity, particularly in young
patients,2,3,7 remain an important thera-
peutic goal in cardiovascular medicine,
which appears to be underachieved at
present.
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Effects of obesity on mortality in
patients with unstable angina
or non-ST-elevation myocardial
infarction: reply
We fully agree with Drs Barton and Husmann
that ﬁndings from observational studies like
ours should be interpreted with caution. In
addition, it is important to emphasize that
observational studies document associations
and are hypotheses generating, but can
hardly ever prove causality. However, we dis-
agree with some other points. (i) It was the
primary aim of our study to compare the
outcome of obese and normal weight
patients. Even after adjustment for all poss-
ible confounders in the multivariable analy-
sis, obesity was associated with a 50%
reduction in mortality.1 In their letter, Drs
Barton and Husmann focus very much on
baseline characteristics in the very obese
patients. Obviously, the subgroup of very
obese patients in our cohort is too small to
allow meaningful statistical analysis or deﬁ-
nite conclusions. Because of a more linear
correlation between body mass index (BMI)
and mortality in our cohort when compared
with a U-shaped correlation in other
studies, comparison of all obese patients
vs. normal BMI patients seemed to be justi-
ﬁed in our analysis.1,2
(ii) Drs Barton and Husmann ﬁnd it ‘daring
to propose a beneﬁcial effect of obesity’. We
consider it our scientiﬁc obligation to report
and discuss ﬁndings as open and unbiased as
possible. The ‘obesity paradox’ is well
described also for heart failure. Increased
BMI is associated with an increase in heart
failure.3 However, after contemporary
treatment of symptomatic heart failure,
the adjusted mortality risk for patients
with lower BMI categories is in the range of
1.2–1.7 when compared with patients with
BMI between 30 and 34.9.4 Some of the
most important advances in medicine have
been the result of unbiased and thoughtful
evaluation of ﬁndings that at ﬁrst sight ques-
tioned prevailing dogmas.5
Importantly, our ﬁnding of an improved
outcome for obese patients after unstable
angina/non-ST-elevation myocardial infarc-
tion treated with early revascularization
should not be misinterpreted. Weight loss
reduces the risk for diabetes and
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2007.
For permissions, please e-mail: journals.permissions@oxfordjournals.org
European Heart Journal (2007) 28, 2950–2954
